...Cryo-Cell and Saneron will study Cryo-Cell’s C’elle menstrual stem cells in preclinical models of undisclosed neurological...
...were not disclosed. Cryo-Cell owns about 38% of Saneron. Cryo-Cell International Inc. (OTCBB:CCEL), Oldsmar, Fla. Saneron CCEL Therapeutics Inc....

...is used to isolate stem cells from umbilical cord blood. Further terms were not disclosed. Saneron CCEL Therapeutics Inc....

...Saneron acquired exclusive, worldwide patent rights to the university's cord blood cell line. Saneron will use...
...neurological and cardiovascular disorders. The university will receive research funding and is eligible for milestones. Saneron CCEL Therapeutics Inc....

...of cord blood stem cell storage play Cryo-Cell (CCEL), will merge with Saneron to form Saneron...
...Ccel Therapeutics. The merged company will combine Ccel Bio-Therapies' U-Cord blood stem cell technology with Saneron's...
...therapies for stroke, brain injuries, Alzheimer's disease and Parkinson's disease. CCEL will own 40% of Saneron...